Contact Us: Sales@finabio.com

Events

10th Global Summit and Expo on Vaccines & Vaccination
June 16-18, 2016, Rome, Italy

Conf-LOGO

 

 

Fina Biosolutions CEO, Andrew Lees will be Keynote Presenter. Dr. Lees will discuss the challenges of developing and manufacturing affordable conjugate vaccines.  He will review how efficient conjugation chemistry and affordable carrier protein can help reduce manufacturing costs.

 

News

  • About FinaBio
    Whitepaper
    Characterization of Fina Biosolutions’ Amino-Dextran
  • About FinaBio

Address

9430 Key West Ave., Suite 200
Rockville, MD 20850
877-346-2246 (877-FinaBio)
301-633-0464 (Andrew Lees, Scientific Director)
Finabio.net
ALees@FinaBio.com

About Us

Fina Biosolutions, LLC was founded in 2006 by Dr. Andrew Lees with an initial focus on helping emerging market vaccine manufacturers learn to make affordable conjugate vaccines. FinaBio has since grown to offer a variety of bioconjugation and protein services. The company is located in the heart of Maryland’s biotechnology corridor.